As researchers refine CRISPR technology to enhance its safety and effectiveness, developing precise and reliable tools is crucial. Ensuring excellence at every step, from early research to application, is essential for creating tools that are safe, specific, and effective.
Watch full BioPharm International interview with Caszyme’s co-founder and CEO, Monika Paulė to learn more about the evolution of CRISPR: https://www.biopharminternational.com/view/bio-2024-seeking-excellence-with-crispr.